News World first as infant gets personalised CRISPR therapy In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation.
R&D Advancing innovation in life sciences R&D and Quality: Towar... This year’s Veeva R&D and Quality Summit saw full-house attendance at the Marriott Auditorium Hotel in Madrid.
R&D Case Study: MHRA Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Patients Sponsored Case Study: MHRA and AstraZeneca Agile, responsive regulation helps early breast cancer patients to benefit from a study to potentially improve survival outcomes.
Oncology Sponsored Case Study: MGI and Alacris Theranostics As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.
News J&J says two drugs are better than one in pretreated myeloma Combining Johnson & Johnson's multiple myeloma therapies Talvey and Tecvayli shows promise in a hard-to-treat form of multiple myeloma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face